Brain injury markers found in the blood months after COVID-19 infection

A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.

SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical

March 17, 2025

No nitrosamines: How parenteral packaging is evolving to meet today’s E&L challenges – Pharmaceutical Technology

In mid-2018, nitrosamine content (specifically N-nitrosodimethylamine, or NDMA) was found to exceed the guidelines on daily intake limits in a widely used hypertension medicine, with

May 22, 2024

Is maternal stress associated with blood glucose levels during pregnancy among women attending a fertility center?

A new study explores stress in relation to glucose levels during treatment at a fertility center since this is likely to impact conception rates and

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.